PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN
Abstract
Authors
P. Lindgren E. Hagström B. van Hout G. Villa P. Pemberton-Ross J. Arellano M. Sibartie G.C. Fonarow